Loading patent…
OwnerMy Svensson, Jeppe Hagstrup Christensen +2inventors
InventorsMy Svensson, Jeppe Hagstrup Christensen, Erik Berg Schmidt, Kaj Anker Jorgensen
Estimating the term…
Omega-3 fatty acid compositions comprising eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are provided, where the compositions are useful for treating, reducing the occurrence of, or preventing major adverse cardiovascular events or major coronary events in patients who have established cardiovascular disease without prior myocardial infarction, preventing their further progression, and treating underlying risk factors for CVD such as hypertension, dyslipidemia, obesity and/or diabetes.
A method of reducing the occurrence of or preventing a major adverse cardiovascular event (MACE) or major coronary event (MCE) in a patient who has established cardiovascular disease without prior myocardial infarction, comprising the steps of:
A method of treating CVD in a patient who has established cardiovascular disease without prior myocardial infarction, comprising the steps of
The method of claim 20, wherein the omega-3 fatty acid composition is provided in a daily dose of about 2 grams per day.
Dependencies are inferred from the claim text.